Targeting the mevalonate pathway is a novel therapeutic approach to inhibit oncogenic FoxM1 transcription factor in human hepatocellular carcinoma
Digital data available
Find on the publisher's website
国立国会図書館デジタルコレクション
Search by Bookstore
Read this material in an accessible format.
Search by Bookstore
Read in Disability Resources
- Other Services
Bibliographic Record
You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.
- Material Type
- 博士論文
- Author/Editor
- 小倉, 智志
- Publication, Distribution, etc.
- Publication Date
- 2018
- Publication Date (W3CDTF)
- 2018
- Alternative Title
- ヒト肝癌において、メバロン酸経路は癌関連タンパクFoxM1転写因子を抑制するための新規治療標的となり得る
- Degree grantor/type
- 大阪大学
- Date Granted
- 2018-06-30
- Date Granted (W3CDTF)
- 2018-06-30